Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 51, 2021 - Issue 7
191
Views
12
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

Oral bioavailability and pharmacokinetics of esculetin following intravenous and oral administration in rats

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 811-817 | Received 10 Mar 2021, Accepted 30 Apr 2021, Published online: 17 May 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Feng Shi, Wenxiong Yin, Michael Adu-Frimpong, Xiaoxiao Li, Xiaoli Xia, Weigang Sun, Hao Ji, Elmurat Toreniyazov, Wang Qilong, Xia Cao, Jiangnan Yu & Ximing Xu. (2023) In-vitro and in-vivo evaluation and anti-colitis activity of esculetin-loaded nanostructured lipid carrier decorated with DSPE-MPEG2000. Journal of Microencapsulation 40:6, pages 442-455.
Read now

Articles from other publishers (11)

Jannatul Ferdous, Md. Shimul Bhuia, Raihan Chowdhury, Asraful Islam Rakib, Mst. Asma Aktar, Md. Sakib Al Hasan, Henrique Douglas Melo Coutinho & Muhammad Torequl Islam. (2024) Pharmacological Activities of Plant‐Derived Fraxin with Molecular Mechanisms: A Comprehensive Review. Chemistry & Biodiversity.
Crossref
Mithun Rudrapal, Gourav Rakshit, Ravi Pratap Singh, Samiksha Garse, Johra Khan & Soumi Chakraborty. (2024) Dietary Polyphenols: Review on Chemistry/Sources, Bioavailability/Metabolism, Antioxidant Effects, and Their Role in Disease Management. Antioxidants 13:4, pages 429.
Crossref
Mengmeng Xia, Zongmei Wu, Junyu Wang, Manon Buist-Homan & Han Moshage. (2023) The Coumarin-Derivative Esculetin Protects against Lipotoxicity in Primary Rat Hepatocytes via Attenuating JNK-Mediated Oxidative Stress and Attenuates Free Fatty Acid-Induced Lipid Accumulation. Antioxidants 12:11, pages 1922.
Crossref
Ting Cai & Bin Cai. (2023) Pharmacological activities of esculin and esculetin: A review. Medicine 102:40, pages e35306.
Crossref
Fang Liu, Jin-Yang Li, Cai-Bei Han, Jun-Hao Wang, Si-Yi Tong, Xue-Kun Wang, Yan-Tuan Li & Wen-Jun Sun. (2023) First cocrystal of esculetin: Simultaneously optimized in vitro/vivo properties and antioxidant effect. European Journal of Pharmaceutical Sciences 187, pages 106469.
Crossref
Vitalii Kostenko, Oleh Akimov, Oleksandr Gutnik, Heorhii Kostenko, Viktoriia Kostenko, Tamara Romantseva, Yevhen Morhun, Svitlana Nazarenko & Olena Taran. (2023) Modulation of redox-sensitive transcription factors with polyphenols as pathogenetically grounded approach in therapy of systemic inflammatory response. Heliyon 9:5, pages e15551.
Crossref
Sourbh Suren Garg, Jeena Gupta, Debasis Sahu & Chuan-Ju Liu. (2022) Pharmacological and Therapeutic Applications of Esculetin. International Journal of Molecular Sciences 23:20, pages 12643.
Crossref
Qian-Hui Wang, Si-Wen Qin & Jian-Guo Jiang. (2022) Improvement effects of esculetin on the formation and development of atherosclerosis. Biomedicine & Pharmacotherapy 150, pages 113001.
Crossref
Hyehyun Hong, Tae-Jin Park, Sungchan Jang, Min-Seon Kim, Jin-Soo Park, Won-Jae Chi & Seung-Young Kim. (2022) Anti-inflammatory activity of 6- O -phospho-7-hydroxycoumarin in LPS-induced RAW 264.7 cells . Journal of Applied Biological Chemistry 65:1, pages 33-41.
Crossref
Biswanath Dinda & Ankita Chakraborty. 2022. Natural Products in Obesity and Diabetes. Natural Products in Obesity and Diabetes 469 505 .
Linlin Zhang, Qingxuan Xie & Xiaofang Li. (2021) Esculetin: A review of its pharmacology and pharmacokinetics. Phytotherapy Research 36:1, pages 279-298.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.